Twist Bioscience Investor Relations Material
Latest events
Q1 2025
Twist Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Twist Bioscience Corporation
Access all reports
Segment Data
Access more data
Revenue by
Product
NGS tools
Synthetic genes
Antibody discovery
Oligo pools
DNA libraries
Expenses by
Financials
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. It offers synthetic DNA-based tools for research and development applications in life sciences. The company also provides molecular biology solutions comprising molecular cloning, next generation sequencing libraries, protein expression, and gene synthesis solutions; cytometry solutions; and biologics solutions for preclinical study. It serves the biotechnology research, pharmaceuticals and drug discovery, diagnostics, chemical manufacturing, agriculture industries, as well as contract research organizations and academic institutions.
Key slides for Twist Bioscience Corporation
Q1 2025
Twist Bioscience Corporation
Q1 2025
Twist Bioscience Corporation
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
TWST
Country
🇺🇸 United States